ZimVie Inc. (NASDAQ:ZIMV) Shares Sold by Centiva Capital LP

Centiva Capital LP cut its holdings in ZimVie Inc. (NASDAQ:ZIMV) by 33.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,000 shares of the company’s stock after selling 7,527 shares during the period. Centiva Capital LP owned about 0.05% of ZimVie worth $238,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Dimensional Fund Advisors LP raised its position in shares of ZimVie by 3.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,035,069 shares of the company’s stock worth $18,889,000 after acquiring an additional 36,846 shares in the last quarter. American Century Companies Inc. raised its holdings in ZimVie by 212.8% during the second quarter. American Century Companies Inc. now owns 412,434 shares of the company’s stock worth $7,527,000 after purchasing an additional 280,565 shares in the last quarter. Renaissance Technologies LLC lifted its position in shares of ZimVie by 26.6% during the 2nd quarter. Renaissance Technologies LLC now owns 406,400 shares of the company’s stock worth $7,417,000 after buying an additional 85,300 shares during the last quarter. First Eagle Investment Management LLC boosted its holdings in shares of ZimVie by 17.1% in the 2nd quarter. First Eagle Investment Management LLC now owns 260,481 shares of the company’s stock valued at $4,754,000 after buying an additional 38,124 shares in the last quarter. Finally, Point72 Asset Management L.P. purchased a new position in shares of ZimVie in the 2nd quarter valued at $3,993,000. 95.63% of the stock is owned by hedge funds and other institutional investors.

ZimVie Price Performance

Shares of ZIMV opened at $14.28 on Thursday. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.94 and a quick ratio of 1.38. ZimVie Inc. has a 1-year low of $10.43 and a 1-year high of $22.40. The stock has a market cap of $394.11 million, a PE ratio of -1.09 and a beta of 2.12. The firm has a fifty day moving average price of $14.44 and a 200 day moving average price of $16.42.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.